These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11425312)

  • 1. Peptide nucleic acids are potent modulators of endogenous pre-mRNA splicing of the murine interleukin-5 receptor-alpha chain.
    Karras JG; Maier MA; Lu T; Watt A; Manoharan M
    Biochemistry; 2001 Jul; 40(26):7853-9. PubMed ID: 11425312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of individual exons and induction of soluble murine interleukin-5 receptor-alpha chain expression through antisense oligonucleotide-mediated redirection of pre-mRNA splicing.
    Karras JG; McKay RA; Dean NM; Monia BP
    Mol Pharmacol; 2000 Aug; 58(2):380-7. PubMed ID: 10908306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense inhibition of membrane-bound human interleukin-5 receptor-alpha chain does not affect soluble receptor expression and induces apoptosis in TF-1 cells.
    Karras JG; McKay RA; Lu T; Dean NM; Monia BP
    Antisense Nucleic Acid Drug Dev; 2000 Oct; 10(5):347-57. PubMed ID: 11079574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo inhibition of interleukin (IL)-5-mediated eosinopoiesis by murine IL-5Ralpha antisense oligonucleotide.
    Lach-Trifilieff E; McKay RA; Monia BP; Karras JG; Walker C
    Am J Respir Cell Mol Biol; 2001 Feb; 24(2):116-22. PubMed ID: 11159044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of base modifications on antisense properties of 2'-O-methoxyethyl and PNA oligonucleotides.
    Sazani P; Astriab-Fischer A; Kole R
    Antisense Nucleic Acid Drug Dev; 2003; 13(3):119-28. PubMed ID: 12954112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of TdT Expression through Splicing Modulation by Antisense Peptide Nucleic Acid (PNA).
    Montazersaheb S; Kazemi M; Nabat E; Nielsen PE; Hejazi MS
    Curr Pharm Biotechnol; 2019; 20(2):168-178. PubMed ID: 30727883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs.
    Sazani P; Kang SH; Maier MA; Wei C; Dillman J; Summerton J; Manoharan M; Kole R
    Nucleic Acids Res; 2001 Oct; 29(19):3965-74. PubMed ID: 11574678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA Secondary Structure-Based Design of Antisense Peptide Nucleic Acids for Modulating Disease-Associated Aberrant Tau Pre-mRNA Alternative Splicing.
    Ong AAL; Tan J; Bhadra M; Dezanet C; Patil KM; Chong MS; Kierzek R; Decout JL; Roca X; Chen G
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31434312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of gene expression inside cells by peptide nucleic acids: effect of mRNA target sequence, mismatched bases, and PNA length.
    Doyle DF; Braasch DA; Simmons CG; Janowski BA; Corey DR
    Biochemistry; 2001 Jan; 40(1):53-64. PubMed ID: 11141056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A highly effective and long-lasting inhibition of miRNAs with PNA-based antisense oligonucleotides.
    Oh SY; Ju Y; Park H
    Mol Cells; 2009 Oct; 28(4):341-5. PubMed ID: 19812898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and functional validation of PNAs that inhibit murine CD40 expression by redirection of splicing.
    Siwkowski AM; Malik L; Esau CC; Maier MA; Wancewicz EV; Albertshofer K; Monia BP; Bennett CF; Eldrup AB
    Nucleic Acids Res; 2004; 32(9):2695-706. PubMed ID: 15148357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repair of thalassemic human beta-globin mRNA in mammalian cells by antisense oligonucleotides.
    Sierakowska H; Sambade MJ; Agrawal S; Kole R
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):12840-4. PubMed ID: 8917506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient and isoform-selective inhibition of cellular gene expression by peptide nucleic acids.
    Liu Y; Braasch DA; Nulf CJ; Corey DR
    Biochemistry; 2004 Feb; 43(7):1921-7. PubMed ID: 14967032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Approach to Developing Splice Modulating Antisense Oligonucleotides.
    Aung-Htut MT; McIntosh CS; Ham KA; Pitout IL; Flynn LL; Greer K; Fletcher S; Wilton SD
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of mdm2 pre-mRNA splicing by 9-aminoacridine-PNA (peptide nucleic acid) conjugates targeting intron-exon junctions.
    Shiraishi T; Eysturskarth J; Nielsen PE
    BMC Cancer; 2010 Jun; 10():342. PubMed ID: 20591158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified (PNA, 2'-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription.
    Boulmé F; Freund F; Moreau S; Nielsen PE; Gryaznov S; Toulmé JJ; Litvak S
    Nucleic Acids Res; 1998 Dec; 26(23):5492-500. PubMed ID: 9826777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of inducible cyclo-oxygenase-2 expression by antisense peptide nucleic acids in intact murine macrophages.
    Scarfì S; Giovine M; Pintus R; Millo E; Clavarino E; Pozzolini M; Sturla L; Stock RP; Benatti U; Damonte G
    Biotechnol Appl Biochem; 2003 Aug; 38(Pt 1):61-9. PubMed ID: 12667143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced soluble interleukin-5 receptor alpha expression in nasal polyposis.
    Gevaert P; Bachert C; Holtappels G; Novo CP; Van der Heyden J; Fransen L; Depraetere S; Walter H; van Cauwenberge P; Tavernier J
    Allergy; 2003 May; 58(5):371-9. PubMed ID: 12752323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short pyrimidine stretches containing mixed base PNAs are versatile tools to induce translation elongation arrest and truncated protein synthesis.
    Sénamaud-Beaufort C; Leforestier E; Saison-Behmoaras TE
    Oligonucleotides; 2003; 13(6):465-78. PubMed ID: 15025913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of potent phosphorothioate antisense oligonucleotides directed to human interleukin 10 gene product and their evaluation of antisense activity in U937 cells.
    Arima H; Takahashi M; Aramaki Y; Sakamoto T; Yuda K; Akiyama K; Goto T; Tsuchiya S
    Pharm Res; 1999 Aug; 16(8):1163-71. PubMed ID: 10468015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.